S&P 500   4,686.75 (+2.07%)
DOW   35,719.43 (+1.40%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
S&P 500   4,686.75 (+2.07%)
DOW   35,719.43 (+1.40%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
S&P 500   4,686.75 (+2.07%)
DOW   35,719.43 (+1.40%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)
S&P 500   4,686.75 (+2.07%)
DOW   35,719.43 (+1.40%)
QQQ   397.83 (+3.01%)
AAPL   171.18 (+3.54%)
MSFT   334.92 (+2.68%)
FB   322.81 (+1.55%)
GOOGL   2,945.39 (+2.87%)
AMZN   3,523.29 (+2.80%)
TSLA   1,051.75 (+4.24%)
NVDA   324.27 (+7.96%)
BABA   125.54 (+1.57%)
NIO   33.12 (+2.41%)
CGC   10.64 (+4.83%)
AMD   144.85 (+4.16%)
GE   97.55 (+1.60%)
MU   85.83 (+4.10%)
T   23.08 (-0.86%)
F   19.96 (+3.85%)
DIS   150.81 (+0.29%)
PFE   51.72 (+0.47%)
AMC   31.04 (+7.82%)
ACB   6.38 (+6.87%)
BA   208.83 (+1.43%)

Echelon Wealth Partners Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Echelon Wealth Partners. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Echelon Wealth Partners.

MarketRank evaluates a company based on community opinion, dividend strength, institutional and insider ownership, earnings and valuation, and analysts forecasts.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyDateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActions
ALYA
Alithya Group
11/11/2021Reiterated byEchelon Wealth PartnersAnalyst A. EzzatBuyHigh
QIPT
Quipt Home Medical
11/9/2021Reiterated byEchelon Wealth PartnersAnalyst S. QuennevilleBuyMedium
SLHG
Skylight Health Group
11/1/2021Reiterated byEchelon Wealth PartnersAnalyst R. GoffSpeculative BuyLow
SLHG
Skylight Health Group
8/30/2021Reiterated byEchelon Wealth PartnersBuyMedium
ALYA
Alithya Group
8/27/2020Reiterated byEchelon Wealth PartnersAnalyst A. EzzatNeutral -> HoldLow
NFE
New Fortress Energy
8/26/2020Initiated byEchelon Wealth PartnersBuy $40.00Low
LMNL
Liminal BioSciences
8/11/2020Reiterated byEchelon Wealth PartnersAnalyst D. LoeHoldLow
THTX
Theratechnologies
7/8/2020Reiterated byEchelon Wealth PartnersBuy $11.00High
LMNL
Liminal BioSciences
7/3/2020Reiterated byEchelon Wealth PartnersHold $21.00High
ACST
Acasti Pharma
6/30/2020Reiterated byEchelon Wealth PartnersAnalyst Douglas LoeBuy $11.20Low
ONCY
Oncolytics Biotech
6/16/2020Reiterated byEchelon Wealth PartnersAnalyst D. LoeSpeculative BuyHigh
ALYA
Alithya Group
6/22/2020Downgraded byEchelon Wealth PartnersAnalyst Amr EzzatBuy -> Hold $2.75Low
IMV
IMV
5/25/2020Reiterated byEchelon Wealth PartnersBuy $9.00Medium
IMV
IMV
2/27/2020Reiterated byEchelon Wealth PartnersBuy $9.00High
ACST
Acasti Pharma
1/8/2020Reiterated byEchelon Wealth PartnersBuy $32.00Medium
PROF
Profound Medical
11/8/2019Reiterated byEchelon Wealth PartnersAnalyst D. LoeBuyLow
IMV
IMV
11/12/2019Reiterated byEchelon Wealth PartnersAnalyst Douglas LoeBuy $12.25Medium
TU
TELUS
11/12/2019Reiterated byEchelon Wealth PartnersBuy $28.00Low
ABUS
Arbutus Biopharma
10/4/2019Downgraded byEchelon Wealth PartnersAnalyst D. LoeHold -> SellLow
AI
C3.ai
8/11/2019Reiterated byEchelon Wealth PartnersBuy $14.00Medium
NEPT
Neptune Wellness Solutions
7/24/2019Reiterated byEchelon Wealth PartnersAnalyst Douglas LoeBuyLow
RCI
Rogers Communications
7/24/2019Upgraded byEchelon Wealth PartnersAnalyst R. GoffHold -> BuyLow
IMV
IMV
6/4/2019Reiterated byEchelon Wealth PartnersAnalyst Douglas LoeBuyMedium
TCX
Tucows
5/9/2019Downgraded byEchelon Wealth PartnersAnalyst G. TucciBuy -> HoldMedium
RCI
Rogers Communications
4/22/2019Downgraded byEchelon Wealth PartnersAnalyst R. GoffBuy -> HoldLow
SJR
Shaw Communications
4/10/2019Reiterated byEchelon Wealth PartnersAnalyst Rob GoffBuyLow
TCX
Tucows
3/19/2019Reiterated byEchelon Wealth PartnersAnalyst Gianluca TucciBuyMedium
ABUS
Arbutus Biopharma
3/11/2019Reiterated byEchelon Wealth PartnersAnalyst D. LoeHoldMedium
TCX
Tucows
2/13/2019Reiterated byEchelon Wealth PartnersAnalyst G. TucciBuyLow
TU
TELUS
2/15/2019Reiterated byEchelon Wealth PartnersAnalyst Rob GoffBuyLow
DSGX
The Descartes Systems Group
1/28/2019Reiterated byEchelon Wealth PartnersAnalyst G. TucciBuyLow
RCI
Rogers Communications
1/25/2019Reiterated byEchelon Wealth PartnersAnalyst R. GoffBuyLow
NEPT
Neptune Wellness Solutions
1/9/2019Reiterated byEchelon Wealth PartnersAnalyst D. LoeBuyLow
TU
TELUS
5/11/2018Target Set byEchelon Wealth PartnersAnalyst Rob GoffBuy $26.00Low
PTE
PolarityTE
9/12/2017Reiterated byEchelon Wealth PartnersBuy $1.60N/A
CGC
Canopy Growth
8/14/2017Target Set byEchelon Wealth PartnersAnalyst Russell StanleyBuy $11.00Low
GPRK
GeoPark
5/25/2017Initiated byEchelon Wealth PartnersBuy $12.00Low
CPE
Callon Petroleum
4/13/2017Upgraded byEchelon Wealth PartnersAnalyst Joel MusanteBuy $17.00Medium
CGC
Canopy Growth
3/22/2017Target Set byEchelon Wealth PartnersAnalyst Russell StanleyBuy $14.00High

MarketBeat Community Rating for Echelon Wealth Partners

Community Ranking:  2.8 out of 5 (star star half star)
Outperform Votes:  17,741 (Vote Outperform)
Underperform Votes:  14,120 (Vote Underperform)
Total Votes:  31,861
MarketBeat's community ratings are surveys of what our community members think about Echelon Wealth Partners and other research firms. Vote "Outperform" if you believe Echelon Wealth Partners's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Echelon Wealth Partners's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.